Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nonprofit Pharmaceutical Companies

495.218
-4.773-0.95%
Number of Gainers:6
Number of Losers:24
Number of Flat:4
PE:- -
High:501.988
Open:500.023
Low:490.944
Close:499.991
Loading ...

Suzhou Basecare Medical Corp. Ltd. Conducted Annual and Class Shareholders Meetings

Reuters
·
Yesterday

Zai Lab Ltd. Announces New Compensation Plan with Grant of Share Options and Restricted Share Units under 2024 Equity Incentive Plan

Reuters
·
Yesterday

Akeso's Pd-1/Ctla-4 Bispecific Antibody Cadonilimab Approved for First-Line Treatment of Cervical Cancer in All-Comer Populations--Third Approved Indication for Cadonilimab

THOMSON REUTERS
·
Yesterday

Akeso Inc. Receives NMPA Approval for Cadonilimab as First-Line Treatment for Cervical Cancer

Reuters
·
Yesterday

Akeso - Nmpa Approved Snda for Cadonilimab as First-Line Treatment for Cervical Cancer

THOMSON REUTERS
·
Yesterday

Zai Lab Ltd. CFO Yajing Chen Reports Disposal of Common Shares

Reuters
·
Yesterday

HBM Holdings Ltd. Files Next Day Disclosure Return to HKEX Announcing Repurchase of 200,000 Shares at HKD 8.7394 Each

Reuters
·
04 Jun

Zhaoke Ophthalmology Ltd. Secures FDA Clearance for IND Application of CsA Ophthalmic Gel for Dry Eye Disease Treatment

Reuters
·
04 Jun

Zhaoke Ophthalmology Ltd - FDA Clearance of Ind Application for Csa Ophthalmic Gel

THOMSON REUTERS
·
04 Jun

BUZZ-Sagimet soars as oral acne drug aces late-stage trial in China

Reuters
·
04 Jun

Sagimet Biosciences Shares Jump 52% Premarket After Oral Acne Drug With Partner Ascletis Met the Main Goals in a Late-Stage Trial

THOMSON REUTERS
·
04 Jun

Sagimet Biosciences Announces Positive Phase 3 Results for Denifanstat in Treating Moderate-to-Severe Acne

Reuters
·
04 Jun

Acotec Scientific Holdings Ltd. Receives PRC National Medical Products Administration Approval for AcoArt Verbena® Paclitaxel-Coated Balloon Catheter

Reuters
·
04 Jun

Acotec Scientific - Approval for Vertebral Artery Paclitaxel-Coated- Balloon Dilatation Catheter Acoart Verbena by Nmpa

THOMSON REUTERS
·
04 Jun

Ascletis Pharma Announces Successful Phase III Trial of Denifanstat, a Groundbreaking Oral FASN Inhibitor for Acne Treatment

Reuters
·
04 Jun

Ascletis Announces Phase Iii Trial of Denifanstat (Asc40), a First-in-Class, Once-Daily Oral Fasn Inhibitor for Acne, Meets All Endpoints

THOMSON REUTERS
·
04 Jun

Ascletis Pharma Inc - Announces Phase Iii Trial of Denifanstat Meets All Endpoints

THOMSON REUTERS
·
04 Jun

HBM Holdings Ltd. Files Next Day Disclosure Return to HKEX Announcing Repurchase of 100,000 Shares at HKD 9.0667 Each

Reuters
·
03 Jun

Brii Biosciences Ltd. Conducted Annual General Meeting

Reuters
·
03 Jun

JW Cayman Therapeutics Co. Ltd. Held Extraordinary General Meeting

Reuters
·
03 Jun